Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial

Peer review reports

Original Submission
28 Aug 2022	Submitted	Original manuscript
2 Nov 2022	Author responded	Author comments - Dawei Yang
Resubmission - Version 2
2 Nov 2022	Submitted	Manuscript version 2
30 Mar 2023	Reviewed	Reviewer Report - Effat Davoudi-Monfared
2 May 2023	Reviewed	Reviewer Report
30 May 2023	Author responded	Author comments - Dawei Yang
Resubmission - Version 3
30 May 2023	Submitted	Manuscript version 3
Publishing
1 Jun 2023	Editorially accepted
15 Jun 2023	Article published	10.1186/s40360-023-00678-7

Back to article page